Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Zinman · SciRah

Researcher profile · Semantic Scholar

B. Zinman

Share profile

B. Zinman — researcher profile on SciRah

h-index: 131
Works: 809
Citations: 83K

Most-cited papers

Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers
C. H. Nørgaard, Sarah Friedrich, C. Hansen, T. Gerds +8 more
2022Alzheimer's & Dementia216 citations Open access
Semantic Scholar
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
Ahmed M. Shaman, Stephen C. Bain, G. Bakris, J. Buse +9 more
2021Circulation203 citations Open access
Semantic Scholar
Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose co-transporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial.
B. Kraus, M. Weir, G. Bakris, M. Mattheus +9 more
2020Kidney International199 citations Open access
Semantic Scholar
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials
B. Neuen, M. Oshima, R. Agarwal, C. Arnott +16 more
2022Circulation190 citations Open access
Semantic Scholar
Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial.
M. Jardine, Zi-En Zhou, K. Mahaffey, M. Oshima +20 more
2020Journal of the American Society of Nephrology134 citations Open access
Semantic Scholar
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2: Subgroup Analysis of the Randomized CREDENCE Trial.
G. Bakris, M. Oshima, K. Mahaffey, R. Agarwal +17 more
2020American Society of Nephrology. Clinical Journal122 citations Open access
Semantic Scholar
The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial
I. Neeland, B. Eliasson, T. Kasai, N. Marx +8 more
2020Diabetes Care87 citations Open access
Semantic Scholar
Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease.
T. Mason, O. Coelho-Filho, S. Verma, Biswajit Chowdhury +13 more
2021JACC Cardiovascular Imaging86 citations Open access
Semantic Scholar
Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
E. Boyko, Leila R. Zelnick, B. Braffett, R. Pop-Busui +5 more
2022Diabetes Care83 citations Open access
Semantic Scholar
Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA‐REG OUTCOME trial
J. Ferreira, S. Inzucchi, M. Mattheus, T. Meinicke +3 more
2021Diabetes, obesity and metabolism61 citations Open access
Semantic Scholar
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial
V. Perkovic, R. Toto, M. Cooper, J. Mann +14 more
2020Diabetes Care56 citations Open access
Semantic Scholar
Effects of Canagliflozin on Cardiovascular, Renal, and Safety Outcomes in Participants With Type 2 Diabetes and Chronic Kidney Disease According to History of Heart Failure: Results From the CREDENCE Trial.
A. Sarraju, Jing-Wei Li, C. Cannon, T. Chang +16 more
2020American Heart Journal53 citations Open access
Semantic Scholar
Insulin and insulin analogs as antidiabetic therapy: A perspective from clinical trials.
C. Kramer, R. Retnakaran, B. Zinman
2021Cell Metabolism52 citations Open access
Semantic Scholar
Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?
Priyadarshini Balasubramanian, C. Wanner, J. Ferreira, A. Ofstad +3 more
2022Journal of Clinical Endocrinology and Metabolism49 citations Open access
Semantic Scholar
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis.
M. Jardine, Zi-En Zhou, H. L. Lambers Heerspink, C. Hockham +19 more
2021American Society of Nephrology. Clinical Journal46 citations Open access
Semantic Scholar
Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial.
D. Feig, J. Sanchez, K. Murphy, E. Asztalos +15 more
2023The Lancet Diabetes and Endocrinology44 citations Open access
Semantic Scholar
Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
G. Biessels, C. Verhagen, J. Janssen, Esther van den Berg +4 more
2021Diabetologia44 citations Open access
Semantic Scholar
Association between uric acid levels and cardio‐renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA‐REG OUTCOME
S. Verma, Q. Ji, Deepak L. Bhatt, C. Mazer +8 more
2020Diabetes, obesity and metabolism43 citations Open access
Semantic Scholar
Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA‐REG OUTCOME trial
P. Pellicori, D. Fitchett, Mikhail N. Kosiborod, A. Ofstad +8 more
2021European Journal of Heart Failure38 citations Open access
Semantic Scholar
Adipose Tissue Insulin Resistance Is Longitudinally Associated With Adipose Tissue Dysfunction, Circulating Lipids, and Dysglycemia: The PROMISE Cohort
Zhila Semnani-Azad, P. Connelly, R. Bazinet, R. Retnakaran +4 more
2021Diabetes Care38 citations Open access
Semantic Scholar
Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial
J. Ferreira, D. Fitchett, A. Ofstad, B. Kraus +7 more
2020American Journal of Hypertension38 citations Open access
Semantic Scholar
Examining the relationship between maternal body size, gestational glucose tolerance status, mode of delivery and ethnicity on human milk microbiota at three months post-partum
Lauren LeMay‐Nedjelski, J. Butcher, S. Ley, Michelle R Asbury +8 more
2020BMC Microbiology37 citations Open access
Semantic Scholar
Subtypes of gestational diabetes and future risk of pre-diabetes or diabetes
R. Retnakaran, C. Ye, A. Hanley, P. Connelly +2 more
2021EClinicalMedicine33 citations Open access
Semantic Scholar
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
T. Yi, B. Smyth, G. D. Di Tanna, C. Arnott +17 more
2023American Journal of Kidney Diseases31 citations Open access
Semantic Scholar
Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes
S. Kahl, A. Ofstad, B. Zinman, C. Wanner +4 more
2022Diabetes, obesity and metabolism31 citations Open access
Semantic Scholar
The discovery of insulin in Toronto: beginning a 100 year journey of research and clinical achievement
Michael Fralick, B. Zinman
2021Diabetologia29 citations
Semantic Scholar
Determinants of Small for Gestational Age in Women With Type 2 Diabetes in Pregnancy: Who Should Receive Metformin?
D. Feig, B. Zinman, E. Asztalos, L. Donovan +4 more
2022Diabetes Care28 citations Open access
Semantic Scholar
The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial.
E. Opingari, S. Verma, K. Connelly, C. Mazer +10 more
2020Nephrology, Dialysis and Transplantation28 citations Open access
Semantic Scholar
Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis
Vinay Garg, S. Verma, K. Connelly, Andrew T. Yan +12 more
2020Metabolism Open26 citations Open access
Semantic Scholar
Liraglutide and semaglutide: Pooled post hoc analysis to evaluate risk of dementia in patients with type 2 diabetes
C. Ballard, Caroline Holm Nørgaard, Sarah Friedrich, L. Mørch +8 more
2020Alzheimer's & Dementia26 citations
Semantic Scholar
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials
S. Verma, S. Bain, J. Honoré, J. Mann +6 more
2020Diabetes, obesity and metabolism23 citations Open access
Semantic Scholar
The impact of canagliflozin on the risk of neuropathy events: a post-hoc exploratory analysis of the CREDENCE trial.
Jin-feng Liao, A. Kang, Chao-yun Xia, T. Young +18 more
2022Diabetes & Metabolism22 citations Open access
Semantic Scholar
Determinants of sustained stabilization of beta-cell function following short-term insulin therapy in type 2 diabetes
R. Retnakaran, Jiajie Pu, Alexandra Emery, S. Harris +5 more
2023Nature Communications21 citations Open access
Semantic Scholar
Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA‐REG OUTCOME trial with a focus on Asia
Q. Ji, L. Ji, Y. Mu, Jia-Jun Zhao +8 more
2021Diabetes, obesity and metabolism21 citations Open access
Semantic Scholar
The ongoing evolution of basal insulin therapy over 100 years and its promise for the future
R. Retnakaran, B. Zinman
2021Diabetes, obesity and metabolism20 citations
Semantic Scholar
Heart failure and renal outcomes according to baseline and achieved blood pressure in patients with type 2 diabetes: results from EMPA-REG OUTCOME.
M. Böhm, D. Fitchett, A. Ofstad, M. Brueckmann +9 more
2020Journal of Hypertension20 citations
Semantic Scholar
Deteriorating beta cell function is the dominant determinant of progression from normal glucose tolerance to prediabetes/diabetes in young women following pregnancy
R. Retnakaran, C. Ye, C. Kramer, A. Hanley +3 more
2023Diabetologia19 citations
Semantic Scholar
Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA‐REG OUTCOME trial
M. Vaduganathan, S. Inzucchi, N. Sattar, D. Fitchett +8 more
2021Diabetes, obesity and metabolism18 citations Open access
Semantic Scholar
Nephrotic-range proteinuria in type 2 diabetes: Effects of empagliflozin on kidney disease progression and clinical outcomes
P. Ruggenenti, B. Kraus, S. Inzucchi, B. Zinman +6 more
2021EClinicalMedicine18 citations Open access
Semantic Scholar
Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes: Insights From the EMPA-REG OUTCOME Trial.
Abhinav K. Sharma, A. Ofstad, Tariq Ahmad, B. Zinman +7 more
2021JACC. Heart failure18 citations Open access
Semantic Scholar
Time to cardiovascular benefits of empagliflozin: a post hoc observation from the EMPA‐REG OUTCOME trial
S. Verma, Lawrence A Leiter, B. Zinman, Abhinav K. Sharma +7 more
2021ESC Heart Failure17 citations Open access
Semantic Scholar
Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial
J. Ferreira, B. Kraus, I. Zwiener, S. Lauer +7 more
2021Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease17 citations Open access
Semantic Scholar
Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial.
J. Lachin, I. Bebu, Xiao-Yu Gao, D. Nathan +1 more
2022Diabetes Care16 citations Open access
Semantic Scholar
Short‐term intensive insulin as induction and maintenance therapy for the preservation of beta‐cell function in early type 2 diabetes (RESET‐IT Main): A 2‐year randomized controlled trial
R. Retnakaran, Alexandra Emery, C. Ye, S. Harris +6 more
2021Diabetes, obesity and metabolism16 citations
Semantic Scholar
Treatment of Gestational Diabetes Mellitus and Maternal Risk of Diabetes After Pregnancy.
R. Retnakaran, C. Ye, A. Hanley, P. Connelly +2 more
2023Diabetes Care15 citations Open access
Semantic Scholar
The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial
R. Retnakaran, C. Ye, Alexandra Emery, C. Kramer +1 more
2022Nature Communications14 citations Open access
Semantic Scholar
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial
C. Arnott, Jing-Wei Li, C. Cannon, D. Zeeuw +15 more
2021Diabetes, obesity and metabolism14 citations Open access
Semantic Scholar
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial
C. Wanner, M. Cooper, O. Johansen, R. Toto +12 more
2021Clinical Kidney Journal14 citations Open access
Semantic Scholar
Impact of polyvascular disease with and without co‐existent kidney dysfunction on cardiovascular outcomes in diabetes: A post hoc analysis of EMPA‐REG OUTCOME
S. Verma, C. Mazer, S. Inzucchi, C. Wanner +6 more
2021Diabetes, obesity and metabolism13 citations Open access
Semantic Scholar
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME®
G. Langslet, B. Zinman, C. Wanner, S. Hantel +3 more
2020Diabetes & vascular disease research13 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Wanner×20
Invite
C. Wanner — researcher profile on SciRah
J. George×12
Invite
J. George — researcher profile on SciRah
V. Perkovic×11
Invite
V. Perkovic — researcher profile on SciRah
A. Ofstad×11
Invite
A. Ofstad — researcher profile on SciRah

×9

Invite

K. Mahaffey — researcher profile on SciRah

Invite

S. Inzucchi — researcher profile on SciRah

Invite

I. Zwiener — researcher profile on SciRah

R. Retnakaran×9

Invite

R. Retnakaran — researcher profile on SciRah

Invite

D. Fitchett — researcher profile on SciRah

Invite

S. Verma — researcher profile on SciRah

Invite

R. Agarwal — researcher profile on SciRah

Invite

D. Wheeler — researcher profile on SciRah